Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis

NCT01666704 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease

Interventions

DRUG: BMS-823778
DRUG: BMS-823778
DRUG: Placebo matching with BMS-823778

Sponsor

Bristol-Myers Squibb